NIMI
VRTX icon

Natixis Investment Managers International’s Vertex Pharmaceuticals VRTX Stock Holding History

Natixis Investment Managers International’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-88,235
Closed -$31.1M – 239
2023
Q2 		$31.1M Sell
88,235
-6,225
-7% -$2.1M 2.3% 18
2023
Q1 		$29.8M Sell
94,460
-16,840
-15% -$5.05M 2.25% 20
2022
Q4 		$32.1M Sell
111,300
-14,825
-12% -$4.52M 2.4% 17
2022
Q3 		$36.5M Sell
126,125
-97,650
-44% -$28.1M 2.92% 14
2022
Q2 		$63.1M Sell
223,775
-4,830
-2% -$1.29M 1.28% 23
2022
Q1 		$59.7M Sell
228,605
-26,125
-10% -$6.2M 1.04% 28
2021
Q4 		$55.9M Buy
+254,730
New +$49.5M 3.1% 15
2018
Q4 		– Sell
-7,409
Closed -$1.43M – 551
2018
Q3 		$1.43M Buy
7,409
+2,153
+41% +$383K 0.07% 270
2018
Q2 		$894K Sell
5,256
-4,133
-44% -$641K 0.05% 304
2018
Q1 		$1.53M Buy
+9,389
New +$1.53M 0.11% 116
2017
Q4 		– Sell
-5,142
Closed -$782K – 349
2017
Q3 		$782K Buy
+5,142
New +$774K 0.07% 204
2015
Q4 		– Sell
-3,784
Closed -$394K – 460
2015
Q3 		$394K Buy
3,784
+474
+14% +$60.9K 0.05% 236
2015
Q2 		$409K Buy
3,310
+973
+42% +$123K 0.05% 244
2015
Q1 		$276K Buy
2,337
+934
+67% +$112K 0.04% 275
2014
Q4 		$167K Buy
+1,403
New +$158K 0.02% 276

Other funds holding VRTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Natixis Investment Managers International's VRTX Position: Q3 2023 in Review

Natixis Investment Managers International sold out of Vertex Pharmaceuticals (VRTX) in Q3 2023, closing a stake of 88,235 shares — an estimated $31.1M sold.

Natixis Investment Managers International first reported a position in VRTX in Q4 2014 and held it in 15 quarters. The position peaked at $63.1M in Q2 2022. 1,278 funds tracked by Wall St. Rank hold VRTX as of Q3 2023.

  • Natixis Investment Managers International reported no remaining Vertex Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Natixis Investment Managers International sold 88,235 Vertex Pharmaceuticals shares in Q3 2023, an estimated $31.1M.
  • Natixis Investment Managers International first reported a position in Vertex Pharmaceuticals in Q4 2014 and held it in 15 quarters.
  • Natixis Investment Managers International's Vertex Pharmaceuticals position peaked at $63.1M in Q2 2022.
  • 1,278 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2023.

Based on Natixis Investment Managers International's 13F filing for Q3 2023, filed 14 Nov 2023.